TGA / PMDA / NMPA · Asia-Pacific
experimental — TGA / PMDA / NMPA regulatory status
experimental regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 31 published clinical programs and 1 related patent record. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| 36-71 months old children-experimental EV71 vaccine. | Phase 3 | Sinovac Research and | NCT03909074 |
| DEXMEDETOMIDINE , 18F-DPA-714 | Phase 3 | PARItec | 2024-511898-30-00 |
| Experimental vaccine | Phase 3 | Sinovac Research and | NCT05386810 |
| Experimental: Tezepelumab | Phase 3 | AstraZeneca | NCT03347279 |
| Experimental: Venetoclax in combination with Decitabine (+-sorafenib) | Phase 3 | Kunming Hope of | NCT06073730 |
| PRO-sIPV-3002 | Phase 3 | Sinovac Research and | NCT04386707 |
| experimental anti-anxiety drug | Phase 3 | Jazz Pharmaceuticals Ireland | NCT00097708 |
| experimental vaccine | Phase 3 | Sinovac Research and | NCT07505810, NCT07505823 |
| 18-0254 | Phase 2 | BRIGHT MINDS BIOSCIENCES | NCT05558358 |
| Experimental | Phase 2 | First People's Hospital | NCT06864013 |
| Experimental: CHF6001 3200 μg | Phase 2 | Chiesi Farmaceutici S.p.A | NCT06029595 |
| Experimental: tislelizumab+anlotinib | Phase 2 | First People's Hospital | NCT06838910 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 8212104 | Model of experimentally induced chronic pain and uses thereof | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of experimental?
experimental currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get experimental regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to experimental?
This spoke lists 31 published programs associated with experimental in our pipeline index.